Omeros Corporation

US$16.92As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OMERHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 7.50%
Div yield —
ROE —
Biotechnology
Beta (5Y) 2.99
PE TTM 10.77
TSR TTM 130.83%
Mkt cap US$1.225B
ROIC (34.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$20
19.62%
(82.03%)
Hold 8|3|5|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.21
0.20
0.20
0.21
19.27%
7.80%
2.79%
9.66%
Revenue$M
109.6
113.0
119.5
123.1
9.38%
7.44%
10.27%
14.96%
Peers (US$1.225B)
Cap (US$)
PE
1.227B
—
1.221B
0.652x
1.214B
—
Capital
TTM
5Y
10Y
Leveragex
1.284
0.651
0.503
EBIT/Intx
1.392
3.136
2.603
Own earn%
237.14
9.84
17.47
Sh yield%
43.42
33.86
34.24
Owners
Insiders/Inst%
9.35
62.98
Short interest%
1.26
SBC / revenue%
3.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
2–14
$1 testx
—
Incr. ROIC%
2